Clinical Trial Update: Busulfan and Melphalan Conditioning in Multiple Myeloma [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 clinical trial evaluating busulfan and melphalan as conditioning therapy in patients with multiple myeloma. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Melphalan (Melphalan)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN